ClinicalTrials.govpublic full text
Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy
diabetes mellitus, type 1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 346880
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.